---
title: "Doximity, Inc. Stock 12‑Month Price Target Cut to $28.11, Implies 20% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286424213.md"
description: "Doximity, Inc.'s average stock price target has been reduced from $36.74 to $31.11, indicating a potential upside of approximately 33% based on the May 13 closing price. The forecasts from 22 analysts range from $17 to $55 per share. The consensus rating remains a 'Buy' from 25 analysts, with 13 Buys, 12 Holds, and no Sells. This information is sourced from FactSet and does not constitute investment advice."
datetime: "2026-05-14T13:20:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286424213.md)
  - [en](https://longbridge.com/en/news/286424213.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286424213.md)
---

# Doximity, Inc. Stock 12‑Month Price Target Cut to $28.11, Implies 20% Upside

-   According to estimates from 22 analysts, Doximity, Inc. stock's average price target has fallen from $36.74 to $31.11, with forecasts ranging from $17 to $55 per share
-   Based on the May 13 closing price, the updated target implies approximately 33% potential upside
-   Consensus rating remains at “Buy” across 25 covering analysts, with 13 Buys, 12 Holds and 0 Sells

Explore more price target data and ratings for Doximity, Inc. on the , and track all previous and future analyst recommendations for Doximity, Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [DOCS.US](https://longbridge.com/en/quote/DOCS.US.md)
- [EKG.US](https://longbridge.com/en/quote/EKG.US.md)
- [LGHT.US](https://longbridge.com/en/quote/LGHT.US.md)
- [HEAL.US](https://longbridge.com/en/quote/HEAL.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Doximity, Inc. (NYSE:DOCS) Given Average Recommendation of "Moderate Buy" by Analysts](https://longbridge.com/en/news/286529492.md)
- [Doximity (NYSE:DOCS) Sets New 52-Week Low After Insider Selling](https://longbridge.com/en/news/286429497.md)
- [Doximity Flags Pharma Ad Market Weakness](https://longbridge.com/en/news/286444124.md)
- [Truist Financial Reiterates "Hold" Rating for Doximity (NYSE:DOCS)](https://longbridge.com/en/news/286436506.md)
- [Doximity plunges 24% on weak guidance, analysts slash PTs on increased AI spending](https://longbridge.com/en/news/286405798.md)